Product
SB-FIX
1 clinical trial
3 indications
Indication
Hemophilia BIndication
Mucopolysaccharidosis Type IIndication
MPS IIClinical trial
Long-Term Follow-up of Subjects Who Were Treated With SB-318, SB-913, or SB-FIX, for Targeted Genome Editing Into the Albumin Gene in the LiverStatus: Active (not recruiting), Estimated PCD: 2030-01-01